HRTX icon

Heron Therapeutics

193 hedge funds and large institutions have $1.1B invested in Heron Therapeutics in 2020 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 81 increasing their positions, 49 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding:

7.31% less ownership

Funds ownership: 109.99%102.69% (-7.3%)

39% less call options, than puts

Call options by funds: $5.87M | Put options by funds: $9.66M

53% less capital invested

Capital invested by funds: $2.33B → $1.1B (-$1.23B)

Holders
193
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.87M
Puts
$9.66M
Net Calls
Net Calls Change

Top Buyers

1 +$29.1M
2 +$16.4M
3 +$10.2M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$6.52M
5
O
OrbiMed
New York
+$6.31M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$439K
102
$435K
103
$429K
104
$427K
105
$418K
106
$386K
107
$375K
108
$375K
109
$363K
110
$351K
111
$349K
112
$346K
113
$331K
114
$315K
115
$303K
116
$299K
117
$281K
118
$269K
119
$268K
120
$250K
121
$241K
122
$240K
123
$236K
124
$235K
125
$218K